Your browser doesn't support javascript.
Occurrence of COVID-19 Symptoms During SARS-CoV-2 Infection Defines Waning of Humoral Immunity.
Wu, Jun; Liang, Bo-Yun; Fang, Yao-Hui; Wang, Hua; Yang, Xiao-Li; Shen, Shu; Chen, Liang-Kai; Li, Su-Meng; Lu, Si-Hong; Xiang, Tian-Dan; Liu, Jia; Le-Trilling, Vu Thuy Khanh; Lu, Meng-Ji; Yang, Dong-Liang; Deng, Fei; Dittmer, Ulf; Trilling, Mirko; Zheng, Xin.
  • Wu J; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Liang BY; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.
  • Fang YH; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Wang H; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.
  • Yang XL; State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
  • Shen S; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Chen LK; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.
  • Li SM; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Lu SH; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.
  • Xiang TD; State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
  • Liu J; Ministry of Education Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Le-Trilling VTK; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Lu MJ; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.
  • Yang DL; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Deng F; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.
  • Dittmer U; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Trilling M; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.
  • Zheng X; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Front Immunol ; 12: 722027, 2021.
Article in English | MEDLINE | ID: covidwho-1399138
ABSTRACT
Approximately half of the SARS-CoV-2 infections occur without apparent symptoms, raising questions regarding long-term humoral immunity in asymptomatic individuals. Plasma levels of immunoglobulin G (IgG) and M (IgM) against the viral spike or nucleoprotein were determined for 25,091 individuals enrolled in a surveillance program in Wuhan, China. We compared 405 asymptomatic individuals who mounted a detectable antibody response with 459 symptomatic COVID-19 patients. The well-defined duration of the SARS-CoV-2 endemic in Wuhan allowed a side-by-side comparison of antibody responses following symptomatic and asymptomatic infections without subsequent antigen re-exposure. IgM responses rapidly declined in both groups. However, both the prevalence and durability of IgG responses and neutralizing capacities correlated positively with symptoms. Regardless of sex, age, and body weight, asymptomatic individuals lost their SARS-CoV-2-specific IgG antibodies more often and rapidly than symptomatic patients did. These findings have important implications for immunity and favour immunization programs including individuals after asymptomatic infections.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunity, Humoral / Asymptomatic Infections / SARS-CoV-2 / COVID-19 / Antibodies, Viral Type of study: Experimental Studies / Observational study / Randomized controlled trials Topics: Long Covid Limits: Adult / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Asia Language: English Journal: Front Immunol Year: 2021 Document Type: Article Affiliation country: Fimmu.2021.722027

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunity, Humoral / Asymptomatic Infections / SARS-CoV-2 / COVID-19 / Antibodies, Viral Type of study: Experimental Studies / Observational study / Randomized controlled trials Topics: Long Covid Limits: Adult / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Asia Language: English Journal: Front Immunol Year: 2021 Document Type: Article Affiliation country: Fimmu.2021.722027